Treatment with metformin yields reductions in total and low-density lipoprotein cholesterol levels in individuals without diabetes, even providing an additional triglyceride-lowering effect among those with polycystic ovary syndrome (PCOS), according to the results of a meta-analysis.
Catheter ablation of atrial fibrillation (AF) appears to be safe for patients with diabetes mellitus (DM), a recent study has found. However, DM increases the rate of relapse of atrial arrhythmia, particularly in those with persistent AF.
Intensive lifestyle intervention seems to be of little benefit in terms of lowering heart failure (HF) risk in type 2 diabetes patients with overweight or obesity when compared with standard diabetes support and education, although weight loss and sustained improvements in cardiorespiratory fitness (CRF) may be protective, according to a study.
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.